Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on TopSecretStocks’s Substack by ...

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones ...

Despite Hims and Hers’ bad Thursday in the markets, it’s important to remember that the company had an amazingly good week. Even after Thursday’s decline, the stock is up 50% over the last five ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other hair care ...

Hims & Hers Health stock plummeted after an FDA decision that prevents the company from selling compounded semaglutide. The company still expects to deliver strong revenue growth, though, and plans to ...

Hims & Hers Health (NYSE:HIMS) is set to report its earnings on Monday, Feb 24 after market close. HIMS stock plunged over 25% on Friday, Feb 21, after the U.S. FDA announced semaglutide is no longer ...

Weight loss drugs are wildly popular these days. Eli Lilly's anti-obesity drug Zepbound brought in more than $1.2 billion in sales during the second quarter alone, and it hasn't even been on the ...

Hims & Hers Health, Inc. impressed with strong Q1 earnings, subscriber growth, and a promising partnership with Novo Nordisk, but didn't guide as well as we all hoped. The two reasons I'm buying are 1 ...